Promoted Content Promoted Content

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): AP-301

            Therapeutic Area: Nephrology Product Name: AP-301

            Highest Development Status: Phase II Product Type: Undisclosed

            Partner/Sponsor/Collaborator: Quan Capital

            Deal Size: $60 million Upfront Cash: Undisclosed

            Deal Type: Series B Financing May 09, 2021

            Details:

            Alebund Pharmaceuticals lead product, AP-301, is a best-in-class potential in the treatment of hyperphosphatemia.